Literature DB >> 724521

A 1:2 crystalline complex of ApA:proflavine: a model for binding to single-stranded regions in RNA.

S Neidle, G Taylor, M Sanderson.   

Abstract

The structure of a 1"2 complex of adenylyl-(3',5')-adenosine phosphate and proflavine hemisulfate has been determined using the methods of x-ray crystallography. Since the ApA does not form a mini double helix, it may serve as a model for the interaction of planar molecules with single stranded nucleic acids. The dinucleotide adopts an extended conformation with the adenines in adjacent molecules forming base pairs. A most unusual feature of the molecule is that it does not obey the "rigid nucleotide" concept although none of the torsion angles occur in energetically unfavourable regions. This is most probably due to the strong interactions between the proflavine and the oligonucleotide.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 724521      PMCID: PMC342758          DOI: 10.1093/nar/5.11.4417

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  The molecular structure of polyadenylic acid.

Authors:  A RICH; D R DAVIES; F H CRICK; J D WATSON
Journal:  J Mol Biol       Date:  1961-02       Impact factor: 5.469

2.  Nucleic acid-mutagen interactions: crystal structure of adenylyl-3',5'-uridine plus 9-aminoacridine.

Authors:  N C Seeman; R O Day; A Rich
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

3.  "Non-rigid" nucleotides in tRNA: a new correlation in the conformation of a ribose.

Authors:  A Jack; A Klug; J E Ladner
Journal:  Nature       Date:  1976-05-20       Impact factor: 49.962

4.  Visualization of drug-nucleic acid interactions at atomic resolution. II. Structure of an ethidium/dinucleoside monophosphate crystalline complex, ethidium:5-iodocytidylyl (3'-5') guanosine.

Authors:  S C Jain; C C Tsai; H M Sobell
Journal:  J Mol Biol       Date:  1977-08-15       Impact factor: 5.469

5.  Structure of a dinucleoside phosphate--drug complex as model for nucleic acid--drug interaction.

Authors:  S Neidle; A Achari; G L Taylor; H M Berman; H L Carrell; J P Glusker; W C Stallings
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

6.  Visualization of drug-nucleic acid interactions at atomic resolution. I. Structure of an ethidium/dinucleoside monophosphate crystalline complex, ethidium:5-iodouridylyl (3'-5') adenosine.

Authors:  C C Tsai; S C Jain; H M Sobell
Journal:  J Mol Biol       Date:  1977-08-15       Impact factor: 5.469

7.  Drug-nucleic acid interactions: conformational flexibility at the intercalation site.

Authors:  H M Berman; S Neidle; R K Stodola
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

Review 8.  RNA structure.

Authors:  N R Kallenbach; H M Berman
Journal:  Q Rev Biophys       Date:  1977-05       Impact factor: 5.318

9.  Crystallographic refinement of yeast phenylalanine transfer RNA at 2-5A resolution.

Authors:  A Jack; J E Ladner; A Klug
Journal:  J Mol Biol       Date:  1976-12-25       Impact factor: 5.469

10.  Yeast phenylalanine transfer RNA: atomic coordinates and torsion angles.

Authors:  G J Quigley; N C Seeman; A H Wang; F L Suddath; A Rich
Journal:  Nucleic Acids Res       Date:  1975-12       Impact factor: 16.971

View more
  3 in total

1.  The influence of terminal 3', 5' phosphates on conformations of dApdA.

Authors:  S Broyde; B Hingerty
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

2.  X-ray-structure of a cytidylyl-3',5'-adenosine-proflavine complex: a self-paired parallel-chain double helical dimer with an intercalated acridine dye.

Authors:  E Westhof; M Sundaralingam
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

3.  The structure of drug-deoxydinucleoside phosphate complex; generalized conformational behavior of intercalation complexes with RNA and DNA fragments.

Authors:  H S Shieh; H M Berman; M Dabrow; S Neidle
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.